Oriola’s restated financial information for 2021 according to the new segment structure

Oriola Corporation Stock Exchange Release 26 April 2022 at 9 a.m.

Oriola’s restated financial information for 2021 according to the new segment structure

Oriola Corporation publishes restated financial information for 2021, following the previously in October 2021 announced changes in its operating model. Furthermore, in February 2022, the company informed about a framework merger agreement with Euroapotheca for combining the respective pharmacy businesses in Sweden. The arrangement is subject to regulatory approval and is expected to be completed during the second half of 2022 at the latest.  

Oriola’s new reporting structure includes continuing operations, which combines the old business areas Pharma and Retail in Finland and Sweden into new Oriola Services segment and discontinued operations, which consists of the Consumer segment including pharmacy operations in Sweden.  

The attached pdf file includes restated financial information for 2021 according to the new reporting structure. These restatements had no impact on the Group’s total figures. The restated figures are unaudited.

Information of coming events

Oriola will publish its Interim report 1 January-31 March 2022 on Thursday, 28 April 2022 approximately at 8.30 a.m.

Oriola will postpone the scheduled CMD until the announced planned merger of the pharmacy operations in Sweden has been completed.

Oriola Corporation                                                                                                                
Sari Pohjonen
CFO

Further information:

Sari Pohjonen, CFO
email: investor.relations@oriola.com

Tuula Lehto
VP, Communications and Sustainability
tel. +358 40 5885 343
email: tuula.lehto@oriola.com

Distribution:
Nasdaq Helsinki Ltd.
Key media

Released by:
Oriola Corporation
Corporate Communications
Orionintie 5
FI-02200 Espoo, Finland
www.oriola.com